MedTrace Logo

Retrospective Analysis of Patients Implanted With 2 Levels of Prodisc® C Vivo Devices

NCT07370493 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-01-27

No results posted yet for this study

Summary

The objective of the study is to evaluate the safety and post-operative performance profile of the prodisc® C Vivo after implantation in comparison to the relevant clinical literature.

Conditions

  • Degenerative Disc Disease
  • Cervical Spine Degenerative Disease
  • Symptomatic Cervical Disc Disease
  • Cervical Spine Degenerative Disc Disease

Interventions

DEVICE

Prodisc C Vivo

The prodisc® C Vivo device is a non-keeled cervical disc replacement prosthesis. The device is modular intervertebral disc prostheses designed to replace a diseased and/or a degenerated disc of the cervical spine in SCDD patients, thereby restoring disc height, biomechanical stability and allowing the potential for motion at the affected vertebral segment.

Sponsors & Collaborators

  • Avania

    collaborator INDUSTRY

  • Centinel Spine

    lead INDUSTRY

Principal Investigators

  • James Kuras, MS · Centinel Spine

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-01
Primary Completion
2030-12-31
Completion
2030-12-31
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07370493 on ClinicalTrials.gov